标题
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1
receptor
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 20, Pages 4790-4805
出版商
Wiley
发表日期
2015-07-27
DOI
10.1111/bph.13250
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
- (2014) Thomas F. Gamage et al. BEHAVIOURAL PHARMACOLOGY
- Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons
- (2014) Robert B. Laprairie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Membrane Proximal Region of the Cannabinoid Receptor CB1 N-Terminus Can Allosterically Modulate Ligand Affinity
- (2013) Jonathan F. Fay et al. BIOCHEMISTRY
- Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action
- (2013) Erin E Cawston et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Co-expression of the human cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexes
- (2013) Amina M. Bagher et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans
- (2013) Richard L. Anderson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)
- (2013) Kwang H. Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients
- (2013) Robert B. Laprairie et al. JOURNAL OF NEUROIMMUNOLOGY
- Emerging paradigms in GPCR allostery: implications for drug discovery
- (2013) Denise Wootten et al. NATURE REVIEWS DRUG DISCOVERY
- Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: Implications for Huntington's disease
- (2013) Robert B. Laprairie et al. NEUROPHARMACOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice
- (2012) Jenny L. Wiley et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and GiProtein-independent ERK1/2 Kinase Activation
- (2012) Kwang H. Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor
- (2012) Francesco Piscitelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Presynaptic CB1 cannabinoid receptors control frontocortical serotonin and glutamate release – Species differences
- (2012) Samira G. Ferreira et al. NEUROCHEMISTRY INTERNATIONAL
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor
- (2012) F. A. Pamplona et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular Loop 2 of the Free Fatty Acid Receptor 2 Mediates Allosterism of a Phenylacetamide Ago-Allosteric Modulator
- (2011) N. J. Smith et al. MOLECULAR PHARMACOLOGY
- Physical and functional interaction between CB1cannabinoid receptors and β2-adrenoceptors
- (2010) Brian D Hudson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist
- (2010) Jenny L. Wiley et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Cannabinoid 1–Receptor Silent Antagonist O-2050 Attenuates Preference for High-Fat Diet and Activated Astrocytes in Mice
- (2010) Sei Higuchi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum
- (2010) X. Wang et al. MOLECULAR PHARMACOLOGY
- Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
- (2010) Peter Keov et al. NEUROPHARMACOLOGY
- Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
- (2008) Roger G. Pertwee ADDICTION BIOLOGY
- Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors
- (2008) Meritxell Canals et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
- (2007) Kazuhide Hayakawa et al. BRAIN RESEARCH
- PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
- (2007) J G Horswill et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started